Cargando…

Inflammatory Myeloradiculitis Secondary to Pembrolizumab: A Case Report and Literature Review

Immune checkpoint inhibitors are the most important new medications in oncology and include inhibitors of programmed cell death protein-1 (PD-1) such as Pembrolizumab, Nivolumab, and Cemiplimab. These anticancer agents prevent tumour immune evasion and have been associated with a range of immune-rel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vickers, M. L., Seidl, B., Bigby, K., Chern, B., Eriksson, L., Hartnett, G., Gericke, C., Chew, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450342/ https://www.ncbi.nlm.nih.gov/pubmed/32908747 http://dx.doi.org/10.1155/2020/8819296

Ejemplares similares

Sars-cov-2-vaccine-inactivated-sinovac-biotech: Myeloradiculitis: case report
Publicado: (2022)

Spinal epidural arteriovenous fistula with nerve root enhancement mimicking myeloradiculitis: a case report
por: Chiang, Sharon, et al.
Publicado: (2023)

Rhombencephalitis and Myeloradiculitis Caused by a European Subtype of Tick-Borne Encephalitis Virus
por: Neill, Lorna, et al.
Publicado: (2019)

Clinical Challenges in a 49-Year-Old Patient with Severe Tick-Borne Myeloradiculitis Despite Complete Active Vaccination
por: Feige, Julia, et al.
Publicado: (2020)

Pembrolizumab: Secondary haemophagocytic lymphohistiocytosis: case report
Publicado: (2021)

Autoimmune diabetes from pembrolizumab: A case report and review of literature
por: Bhanderi, Hardikkumar, et al.
Publicado: (2023)

Case report: Bilateral uveitis and papillitis secondary to treatment with pembrolizumab
por: Navarro-Perea, Carmen, et al.
Publicado: (2019)

Non-gestational choriocarcinoma with hyperprogression on pembrolizumab: A case report and review of the literature
por: Kazemi, Nazanin Yeganeh, et al.
Publicado: (2022)

Use of pembrolizumab in MSI-high uterine leiomyosarcoma; a case report and review of the literature
por: Wang, Yannan J., et al.
Publicado: (2021)

Radiation Recall Dermatitis Following Treatment With Pembrolizumab: A Case Report and Review of the Literature
por: Sandhu, Michael, et al.
Publicado: (2023)

Critical Care Admission of an HIV Patient with Diabetic Ketoacidosis Secondary to Pembrolizumab
por: Cuenca, John A., et al.
Publicado: (2020)

Scleroderma Secondary to Pembrolizumab: A Case Report and Review of 19 Cases of Anti-PD-1-Induced Scleroderma
por: Farrugia, Stephanie, et al.
Publicado: (2023)

Disseminated Mycobacterium abscessus Infection Secondary to an Infected Vascular Stent: Case Report and Review of the Literature
por: Tejura, Nilesh, et al.
Publicado: (2018)

Bullous pemphigoid secondary to pembrolizumab mimicking toxic epidermal necrolysis
por: Qiu, Connie, et al.
Publicado: (2020)

Acute anti-Ma2 paraneoplastic encephalitis associated to pembrolizumab: a case report and review of literature
por: Albarrán, Víctor, et al.
Publicado: (2021)

Hemophagocytic lymphohistiocytosis in two patients following treatment with pembrolizumab: two case reports and a literature review
por: Wei, Yanqiu, et al.
Publicado: (2022)

Clinical course and management of insidious adrenal crisis manifested initially as hyperpyrexia secondary to pembrolizumab: Case reports and literature review
por: Geng, Dandan, et al.
Publicado: (2022)

Serendipitous synergism – an exceptional response to treatment with pembrolizumab in the course of a natural immunovirotherapy: a case report and review of the literature
por: Khoury, Lara M., et al.
Publicado: (2022)

Simultaneous Presentation of Secondary Adrenal Insufficiency and Primary Hypothyroidism due to Pembrolizumab: A Case Report
por: Khatri, Shivam, et al.
Publicado: (2023)

Pembrolizumab-Induced Myasthenia Gravis: A Case Report and Review of the Literature
por: Eglenen Polat, Buse, et al.
Publicado: (2023)

Case Reports of Pembrolizumab-induced Acute Inflammatory Demyelinating Polyneuropathy
por: Manam, Rupesh, et al.
Publicado: (2018)

Safe Transition to Pembrolizumab following Ipilimumab-Induced Guillain-Barré Syndrome: A Case Report and Review of the Literature
por: Gravbrot, Nicholas, et al.
Publicado: (2019)

Pembrolizumab for the treatment of Progressive Multifocal Leukoencephalopathy (PML) in a patient with AIDS: A case report and literature review
por: Chatterjee, Tulika, et al.
Publicado: (2022)

A Rare Case of Autoimmune Demyelinating Polyneuropathy and Hydrocephalus Secondary to Pembrolizumab
por: Arora, Aakriti, et al.
Publicado: (2020)

Exudative pharyngitis and Corynebacterium pseudodiphtheriticum: A case report and review of the literature
por: Reddy, Kessendri, et al.
Publicado: (2021)

Pembrolizumab: Various toxicities: case report
Publicado: (2021)

SJS/TEN immune-related dermatologic reaction secondary to immune checkpoint inhibitor pembrolizumab in skin of color
por: Pierre, A.B., et al.
Publicado: (2023)

Primary malignant melanoma of the uterine cervix treated with pembrolizumab after radical surgery: a case report and literature review
por: Kim, Myeong Seon, et al.
Publicado: (2018)

Radiation myelitis after pembrolizumab administration, with favorable clinical evolution and safe rechallenge: a case report and review of the literature
por: Carausu, Marcela, et al.
Publicado: (2019)

Pericardial tamponade during pembrolizumab treatment in a patient with advanced lung adenocarcinoma: A case report and review of the literature
por: Harada, Kazuaki, et al.
Publicado: (2020)

Pembrolizumab-induced Stevens-Johnson syndrome in advanced squamous cell carcinoma of the lung: A case report and review of literature
por: Wu, Jing-Yi, et al.
Publicado: (2022)

Pathological Complete Response of Metastatic Clear Cell Renal Carcinoma with Pembrolizumab and Axitinib: A Case Report and Review of Literature
por: Beirat, Amir F., et al.
Publicado: (2023)

Pembrolizumab-Induced Lichen Planus Pemphigoides in a Patient with Metastatic Adrenocortical Cancer: A Case Report and Literature Review
por: Madan, Vrinda, et al.
Publicado: (2023)

Pembrolizumab-Induced Acute Skin Reaction: A Case Report and Review of Literature
por: Thomas, Mathew, et al.
Publicado: (2022)

Interstitial Pneumonitis Secondary to Trastuzumab: A Case Report and Literature Review
por: Costa, Ricardo, et al.
Publicado: (2017)

Secondary sclerosing cholangitis as a complication of severe COVID‐19: A case report and review of the literature
por: Klindt, Caroline, et al.
Publicado: (2021)

Acute Pancreatitis Secondary to Pembrolizumab-Induced Hypertriglyceridemia
por: Ashfaq, Ammar, et al.
Publicado: (2023)

Pembrolizumab: COVID-19 infection: case report
Publicado: (2021)

Pembrolizumab: Interstitial bilateral pneumonitis: case report
Publicado: (2021)

Pembrolizumab: Guillain Barre Syndrome: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hovmegm09cll5phojgqdglmrsa